JAMIE GRAVES: Open Payments
NPI 1811295629 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 141 payments from 13 companies in 2025. Trend: 2023 $1,204 · 2024 $1,704 · 2025 $2,593
Food & beverage: $2,484Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $402 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $400 |
| Neurocrine BioSciences, Inc. | 15 | $366 |
| Otsuka America Pharmaceutical, Inc. | 22 | $341 |
| Alkermes, Inc. | 10 | $215 |
| E.R. Squibb & Sons, L.L.C. | 12 | $167 |
| Janssen Pharmaceuticals, Inc | 15 | $159 |
| Lundbeck LLC | 11 | $156 |
| Axsome Therapeutics, Inc. | 8 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $138 |
Products named: CAPLYTA, INGREZZA, REXULTI, ARISTADA, UZEDY, COBENFY, INVEGA SUSTENNA, Auvelity.
Industry payments across TN — which companies pay providers there.
